跳至主要内容
临床试验/IRCT2012121511738N2
IRCT2012121511738N2已完成2 期

Effect of N-Acetyl cysteine on the success rate of H.pylori eradication

Vice Chancellor for Research of Tabriz University of Medical Sciences0 个研究点目标入组 230 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
230

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 no limit(—)
性别
All

入选标准

  • patients older than 20 years old, HP positive patients at the time of an injection molded pylori eradication indicated they have not previously received eradication regimen, the patients who have NAC in past month.
  • Exclusion criteria: history of gastrectomy, gastric cancer includes adenocarcinoma, previous allergic reaction to antibiotics (amoxicillin and clarithromycin), NAC and proton pump inhibitors (omeprazole), pregnant and lactating women, concurrent severe illness, phenyl ketone Avery, taking antibiotics or NAC now or in the past month and is patient's dissatisfaction.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research of Tabriz University of Medical Sciences

相似试验